LEP and breast cancer: In MCF-7/HER2 BC cells, leptin can render HER2-overexpressing cells resistant to tamoxifen by acting synergistically with the leptin/Ob–Rb/STAT3 pathway and the HER2 receptor to differentially regulate apoptosis-related genes [90].